drugset / Trial / NCT01152931

Antioxidant Micronutrients in Malaria

NCT01152931

Phase 3 Completed 10 enrolled University of Lagos, Nigeria
RandomizedSingle-groupOpen-labelTreatment

Summary

In the last decade, the prevalence of malaria has been escalating at an alarming rate, especially in Africa. An estimated 300 to 500 million cases each year cause 1.5 to 2.7 million deaths, more than 90% occur in children under 5 years of age in Africa (WHO 1995). Malaria is Africa's leading cause of under-five mortality (20%) and constitutes 10% of the continent's overall disease burden. It accounts for 40% of public health expenditure, 30-50% of inpatient admissions, and up to 50% of outpatient visits in areas with high malaria transmission. Antioxidant micronutrients have immunomodulatory role and may have suppressive activity.

Timeline

Start
2010-08
Primary completion
2010-11
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Artemether Small molecule 20 mg Oral
Comparator Artesunate Small molecule 50 mg Oral
Comparator amodiaquine Other / unclassified 10 mg/kg Oral
Comparator lumefantrine Small molecule 120 mg Oral

Indications